However, the current study still outstands itself in that we incorporated the more modern TKI therapy into the variables to uncover the prognostic value of CD13/CD33 expression in a large real‐world adult B‐ALL cohort. The gene discussed is ANPEP; the disease is acute lymphoblastic leukemia.